C87H76F10Ir4N17O8Os-4 — CID 159524173
2-[4,5-bis(trifluoromethyl)imidazol-3-id-2-yl]pyridine;2-(4,5-dimethylimidazol-3-id-2-yl)pyridine;tetrakis(4-hydroxypent-3-en-2-one);tetrakis(iridium);2-(4-methyl-2-pyridinyl)benzimidazol-1-ide;osmium(1+);2-pyridin-2-ylbenzimidazol-1-ide;2-pyridin-2-ylpyridine;4,5,6,7-tetrafluoro-2-pyridin-2-ylbenzimidazol-1-ide (PubChem CID 159524173) has the molecular formula C87H76F10Ir4N17O8Os-4 and a molecular weight of 2636.75 g/mol. Its IUPAC name is 2-[4,5-bis(trifluoromethyl)imidazol-3-id-2-yl]pyridine;2-(4,5-dimethylimidazol-3-id-2-yl)pyridine;tetrakis(4-hydroxypent-3-en-2-one);tetrakis(iridium);2-(4-methyl-2-pyridinyl)benzimidazol-1-ide;osmium(1+);2-pyridin-2-ylbenzimidazol-1-ide;2-pyridin-2-ylpyridine;4,5,6,7-tetrafluoro-2-pyridin-2-ylbenzimidazol-1-ide.
| Compound Name | 2-[4,5-bis(trifluoromethyl)imidazol-3-id-2-yl]pyridine;2-(4,5-dimethylimidazol-3-id-2-yl)pyridine;tetrakis(4-hydroxypent-3-en-2-one);tetrakis(iridium);2-(4-methyl-2-pyridinyl)benzimidazol-1-ide;osmium(1+);2-pyridin-2-ylbenzimidazol-1-ide;2-pyridin-2-ylpyridine;4,5,6,7-tetrafluoro-2-pyridin-2-ylbenzimidazol-1-ide |
|---|---|
| PubChem CID | 159524173 |
| Molecular Formula | C87H76F10Ir4N17O8Os-4 |
| Molecular Weight | 2636.75 g/mol |
| Exact Mass | 2640.41 |
| IUPAC Name | 2-[4,5-bis(trifluoromethyl)imidazol-3-id-2-yl]pyridine;2-(4,5-dimethylimidazol-3-id-2-yl)pyridine;tetrakis(4-hydroxypent-3-en-2-one);tetrakis(iridium);2-(4-methyl-2-pyridinyl)benzimidazol-1-ide;osmium(1+);2-pyridin-2-ylbenzimidazol-1-ide;2-pyridin-2-ylpyridine;4,5,6,7-tetrafluoro-2-pyridin-2-ylbenzimidazol-1-ide |
| SMILES | CC(=O)C=C(C)O.CC(=O)C=C(C)O.CC(=O)C=C(C)O.CC(=O)C=C(C)O.Cc1ccnc(-c2nc3ccccc3[n-]2)c1.Cc1nc(-c2ccccn2)[n-]c1C.FC(F)(F)c1nc(-c2ccccn2)[n-]c1C(F)(F)F.Fc1c(F)c(F)c2[n-]c(-c3ccccn3)nc2c1F.[Ir].[Ir].[Ir].[Ir].[Os+].c1ccc(-c2ccccn2)nc1.c1ccc(-c2nc3ccccc3[n-]2)nc1 |
| InChI | InChI=1S/C13H10N3.C12H4F4N3.C12H8N3.C10H4F6N3.C10H10N3.C10H8N2.4C5H8O2.4Ir.Os/c1-9-6-7-14-12(8-9)13-15-10-4-2-3-5-11(10)16-13;13-6-7(14)9(16)11-10(8(6)15)18-12(19-11)5-3-1-2-4-17-5;1-2-6-10-9(5-1)14-12(15-10)11-7-3-4-8-13-11;11-9(12,13)6-7(10(14,15)16)19-8(18-6)5-3-1-2-4-17-5;1-7-8(2)13-10(12-7)9-5-3-4-6-11-9;1-3-7-11-9(5-1)10-6-2-4-8-12-10;4*1-4(6)3-5(2)7;;;;;/h2-8H,1H3;1-4H;1-8H;1-4H;3-6H,1-2H3;1-8H;4*3,6H,1-2H3;;;;;/q5*-1;;;;;;;;;;+1 |
| InChIKey | VULMTVWZJFUOTN-UHFFFAOYSA-N |
| XLogP | 18.76 |
| TPSA | 374.38 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 20 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 127 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2636.75 |
| LogP ≤ 5 | 18.76 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 20 |
| Structural Alerts | {'alert_name': 'acyclic_C=C-O', 'substructure': 'N/A'}, {'alert_name': 'halogenated_ring_1', 'substructure': 'N/A'}, {'alert_name': 'halogenated_ring_2', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|